MACK ANTHONY P. (Chief Executive Officer) purchased 42.8% of their position (75.75K shares) of VIRPAX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $101.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2022ACC: 0001493152-22-014659
DirectorOfficer· Chief Executive Officer
Since Feb 2021
+75.75K
Net shares
Net buyer
$101.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
75.75K acquired
Non-Derivative Transactions1
Common Stock, $0.00001 par value
Direct
Shares
+75.75K
Price / share
$1.34
Trade value
$101.50K
% of position
42.8%
5/18/2022
176.81K→252.56K
Total
Net shares
+75.75K
Net value
$101.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 par value Direct | 5/18/2022 | P · Purchase | +75.75K | $1.34 | $101.50K | 42.8% | 176.81K | 252.56K |
| Total | +75.75K | $101.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.00001 par value
IndirectShares owned2.73M
Total
2.73M indirect2.73M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.00001 par value | 2.73M | Indirect |
| Total | 2.73M | 2.73M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported